Skip to main content

FDA recall, , Moderate risk

Beckman Coulter MicroScan Neg Multidrug Resistant MIC 1 Panels

MicroScan Neg Multidrug Resistant MIC 1 has a manufacturing issue with in vitro multidrug resistant test.

What happened

Beckman Coulter, Inc., of West Sacramento, California, recalled MicroScan Neg Multidrug Resistant MIC 1 REF C32368, a test used with MicroScan Dried Gram Negative MIC/Combo Panels and Dried Gram Negative Breakpoint Combo Panels for determining antimicrobial susceptibility of gram-negative bacilli.

The recall began September 8, 2025, due to a manufacturing issue with incorrectly processing the in vitro multidrug resistant test. The product was distributed internationally to Poland, and the FDA added it to its Enforcement Report on April 8, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the UDI-DI and lot code listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. MicroScan Neg Multidrug Resistant MIC 1 REF C32368 UDI-DI code: 15099590720568 Intended Use- For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dried Gram Negative Breakpoint Combo Panels. MicroScan panels

    UDI-DI
    • 15099590720568
    Lot code
    • 2026-05-08

Recall details

Company began the recall
Sold in

International distribution to the country of Poland.

Company
Beckman Coulter, Inc.West Sacramento, California
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98562
Recall number
Z-1794-2026
Quantity recalled
3 boxes

All recalls from Beckman Coulter, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)